Curida Launches New Unified Brand Identity

To celebrate its 10^th anniversary, Curida AS, a European Contract Development and Manufacturing Organization (CDMO), has launched a new website and unified brand identity.

Local dignitaries and leadership, old and new, joined the Curida team on the 29th of August to celebrate this strategic move which reflects Curida’s evolution into a full-spectrum CDMO partner for both pharmaceutical and diagnostic companies.

“We’ve grown significantly over the past few years, both in services and customers across multiple regions and in terms of scope and geography,” said Anders Larsson, CEO of Curida. “Bringing all parts of the business together under one name and one platform is a natural next step — and an important signal to the market that we are a unified partner, ready to deliver at scale and with speed.”

The update brings together Curida’s three business units under a single, integrated brand. The company’s consolidated capabilities now include:

• Nasal Spray & Ophthalmic Solutions, including drug product manufacturing and development for uni-dose and multi-dose formats and for suspensions & Controlled drugs.
• End-to-end CDMO support from early development and tech transfer to commercial-scale manufacturing.
• Specialized Biologics & Diagnostic Solutions, including monoclonal antibody manufacturing for IVD.
• Pharmacy Formulations – Specialized pharmaceutical manufacturing for Norwegian pharmacies and cosmetic and nutrition clients.

The consolidated brand reflects a broader wave of strategic investments across Curida’s sites, people, and platforms. With a growing and diverse team across Europe, the company continues to build on its commitment to quality, delivery, and agility in a fast-changing market.

“Our focus is on being a responsive, high-quality CDMO partner — one that understands our customers’ timelines and challenges,” added Larsson. The brand reflects who we are: forward-looking, unified, and driven to support better patient outcomes through trusted partnerships.”